A substantial proportion of risk for Parkinson's disease (PD) is driven by genetics. Progress
in understanding the genetic basis of PD has been significant. So far, highly-penetrant rare …

Personalized medicine promises individualized disease prediction and treatment. The
convergence of machine learning (ML) and available multimodal data is key moving forward. We …

Background An understanding of the genetic mechanisms underlying diseases in ancestrally
diverse populations is an important step towards development of targeted treatments. …

Background GBA1 variants are among the most common genetic risk factors for Parkinson's
disease (PD). GBA1 variants can be classified into three categories based on their role in …

Although over 90 independent risk variants have been identified for Parkinson’s disease
using genome-wide association studies, most studies have been performed in just one …

Genome-wide association studies (GWAS) of Alzheimer’s disease are predominantly carried
out in European ancestry individuals despite the known variation in genetic architecture …

Parkinson’s disease has a large heritable component and genome-wide association studies
have identified over 90 variants with disease-associated common variants, providing …

Background The Iberian Peninsula stands out as having variable levels of population admixture
and isolation, making Spain an interesting setting for studying the genetic architecture of …

Multiple genes have been associated with monogenic Parkinson's disease and Parkinsonism
syndromes. Mutations in PINK1 (PARK6) have been shown to result in autosomal …

Background Understanding the genetic mechanisms underlying diseases in ancestrally diverse
populations is a critical step towards the realization of the global application of precision …